These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27109047)

  • 21. Oncogenic features of the JMJD2A histone demethylase in breast cancer.
    Berry WL; Shin S; Lightfoot SA; Janknecht R
    Int J Oncol; 2012 Nov; 41(5):1701-6. PubMed ID: 22948256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis.
    Lunardi A; Varmeh S; Chen M; Taulli R; Guarnerio J; Ala U; Seitzer N; Ishikawa T; Carver BS; Hobbs RM; Quarantotti V; Ng C; Berger AH; Nardella C; Poliseno L; Montironi R; Castillo-Martin M; Cordon-Cardo C; Signoretti S; Pandolfi PP
    Cancer Discov; 2015 May; 5(5):550-63. PubMed ID: 25653093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing the epigenetic silencer KDM4A for TRAIL and DR5 simultaneous induction and antitumor therapy.
    Wang J; Wang H; Wang LY; Cai D; Duan Z; Zhang Y; Chen P; Zou JX; Xu J; Chen X; Kung HJ; Chen HW
    Cell Death Differ; 2016 Nov; 23(11):1886-1896. PubMed ID: 27612013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells.
    Machado-Neto JA; Lazarini M; Favaro P; Franchi GC; Nowill AE; Saad ST; Traina F
    Exp Cell Res; 2014 Jun; 324(2):137-45. PubMed ID: 24726915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The histone demethylase JMJD2A/KDM4A links ribosomal RNA transcription to nutrients and growth factors availability.
    Salifou K; Ray S; Verrier L; Aguirrebengoa M; Trouche D; Panov KI; Vandromme M
    Nat Commun; 2016 Jan; 7():10174. PubMed ID: 26729372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA KIKAT/LINC01061 as a novel epigenetic regulator that relocates KDM4A on chromatin and modulates viral reactivation.
    Yang WS; Yeh WW; Campbell M; Chang L; Chang PC
    PLoS Pathog; 2021 Jun; 17(6):e1009670. PubMed ID: 34111227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer.
    Selth LA; Das R; Townley SL; Coutinho I; Hanson AR; Centenera MM; Stylianou N; Sweeney K; Soekmadji C; Jovanovic L; Nelson CC; Zoubeidi A; Butler LM; Goodall GJ; Hollier BG; Gregory PA; Tilley WD
    Oncogene; 2017 Jan; 36(1):24-34. PubMed ID: 27270433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic activation of AP1 promotes squamous cell carcinoma metastasis.
    Ding X; Pan H; Li J; Zhong Q; Chen X; Dry SM; Wang CY
    Sci Signal; 2013 Apr; 6(273):ra28.1-13, S0-15. PubMed ID: 23633675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM).
    Lapidot M; Case AE; Weisberg EL; Meng C; Walker SR; Garg S; Ni W; Podar K; Hung YP; Carrasco RD; Knott A; Gokhale PC; Sharma S; Pozhitkov A; Kulkarni P; Frank DA; Salgia R; Griffin JD; Saladi SV; Bueno R; Sattler M
    Br J Cancer; 2021 Aug; 125(4):582-592. PubMed ID: 34088988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis.
    Ye S; Lawlor MA; Rivera-Reyes A; Egolf S; Chor S; Pak K; Ciotti GE; Lee AC; Marino GE; Shah J; Niedzwicki D; Weber K; Park PMC; Alam MZ; Grazioli A; Haldar M; Xu M; Perry JA; Qi J; Eisinger-Mathason TSK
    Cancer Res; 2018 May; 78(10):2705-2720. PubMed ID: 29490948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene-specific methylation control of H3K9 and H3K36 on neurotrophic BDNF versus astroglial GFAP genes by KDM4A/C regulates neural stem cell differentiation.
    Cascante A; Klum S; Biswas M; Antolin-Fontes B; Barnabé-Heider F; Hermanson O
    J Mol Biol; 2014 Oct; 426(20):3467-77. PubMed ID: 24747049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and characterization of PKF118-310 as a KDM4A inhibitor.
    Franci G; Sarno F; Nebbioso A; Altucci L
    Epigenetics; 2017 Mar; 12(3):198-205. PubMed ID: 27767379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SND1 binds to ERG and promotes tumor growth in genetic mouse models of prostate cancer.
    Liao SY; Rudoy D; Frank SB; Phan LT; Klezovitch O; Kwan J; Coleman I; Haffner MC; Li D; Nelson PS; Emili A; Vasioukhin V
    Nat Commun; 2023 Nov; 14(1):7435. PubMed ID: 37973913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
    Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
    Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HNF4α and CDX2 Regulate Intestinal
    Larsen S; Davidsen J; Dahlgaard K; Pedersen OB; Troelsen JT
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic Target.
    Lee RS; Zhang L; Berger A; Lawrence MG; Song J; Niranjan B; Davies RG; Lister NL; Sandhu SK; Rubin MA; Risbridger GP; Taylor RA; Rickman DS; Horvath LG; Daly RJ
    Neoplasia; 2019 Apr; 21(4):389-400. PubMed ID: 30901730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer.
    Butler MS; Roshan-Moniri M; Hsing M; Lau D; Kim A; Yen P; Mroczek M; Nouri M; Lien S; Axerio-Cilies P; Dalal K; Yau C; Ghaidi F; Guo Y; Yamazaki T; Lawn S; Gleave ME; Gregory-Evans CY; McIntosh LP; Cox ME; Rennie PS; Cherkasov A
    Oncotarget; 2017 Jun; 8(26):42438-42454. PubMed ID: 28465491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer.
    Song S; Honjo S; Jin J; Chang SS; Scott AW; Chen Q; Kalhor N; Correa AM; Hofstetter WL; Albarracin CT; Wu TT; Johnson RL; Hung MC; Ajani JA
    Clin Cancer Res; 2015 Jun; 21(11):2580-90. PubMed ID: 25739674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer.
    Wang S; Kollipara RK; Humphries CG; Ma SH; Hutchinson R; Li R; Siddiqui J; Tomlins SA; Raj GV; Kittler R
    Oncotarget; 2016 Oct; 7(40):64921-64931. PubMed ID: 27626314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2.
    Mao N; Gao D; Hu W; Gadal S; Hieronymus H; Wang S; Lee YS; Sullivan P; Zhang Z; Choi D; Rosen N; Sawyers CL; Gopalan A; Chen Y; Carver BS
    Cancer Res; 2020 Apr; 80(7):1428-1437. PubMed ID: 32015092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.